Chronic pulmonary heart disease with acute exacerbation of clinical treatment of respiratory failure.docVIP

 PAGE \* MERGEFORMAT 11 Chronic pulmonary heart disease with acute exacerbation of clinical treatment of respiratory failure [Abstract] Section I of nosocomial pulmonary heart disease were treated in four years, acute exacerbation of respiratory failure in patients with 153 cases by integrated Chinese and Western medicine treatment effect is significant, using an active infection control and improve the ventilation function. To correct heart failure, oxygen therapy, nutrition, heart, pay attention to water-electrolyte balance during treatment using a variety of adjustment programs. In accordance with the 1997 National Conference on Pulmonary Heart Disease Pulmonary Heart Disease revised the standard to determine efficacy of a comprehensive, effective in 137 cases, improved in 13 cases, 3 died, efficiency 98.0%, mortality 1.9%. In summary, pulmonary heart disease with acute exacerbation of respiratory failure is the condition of varied, complex and require careful analysis of the specific circumstances of each case, grasp the key, adopt appropriate measures, in order to obtain satisfactory outcome. [Keywords:] chronic pulmonary heart disease clinical treatment of respiratory failure Chronic pulmonary heart disease (pulmonary heart disease, chronic rulmonary heart disease, CRHD) are due to chronic lung and thoracic disease or pulmonary vascular disease caused by increased pulmonary vascular resistance, pulmonary hypertension, thereby causing right ventricular hypertrophy, right ventricular function to expand or even failure, heart disease, often complicated by respiratory failure, respiratory medicine in our hospital were treated in four years, with acute exacerbation of pulmonary heart disease 153 cases of respiratory failure by integrated Chinese and Western medicine treatment effect is significant, are reported as follows. A clinical data 1.1 General information on 153 cases in men and 87 cases, female 66 cases; aged 43 to 86 years of age, duration (9.0 ±